[1] |
XIN Yumeng, LIANG Huanxi, YU Yuehua, SUN Zhenxiao.
Network pharmacology and molecular docking mechanisms of licorice and dried ginger decoction against breast cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 7-13.
|
[2] |
ZHAO Yan, SUN Zhenxiao.
Metformin inhibitd proliferation and migration of human breast cancer cell in vitro
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 35-39.
|
[3] |
FANG Yutong, ZHANG Qunchen, HONG Chaoqun, CHEN Chunfa, CHEN Jiongyu, ZHANG Rendong, WU Jundong.
Mechanisms of miR-221 and miR-222 on expression of GATA3 and FOXA1 and their effects in breast cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 435-441,460.
|
[4] |
ZHANG Shimin, ZHAO Ruijun.
Expression of protein tyrosine phosphatase receptor J in breast cancer tissues and its relationship with clinical prognosis
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 276-279,285.
|
[5] |
HUANG Xiaohua, NIU Yongdong, SHI Ganggang.
Inhibitory effects and mechanisms of nuclear receptor FXR activation in cervical cancer cell line CaSki
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 302-306.
|
[6] |
CHENG Bin, WANG Xinyu, SUN Yu, ZHANG Jiatai, DONG Shuying.
Inhibition of metformin on phthalate-induced proliferation and migration of MCF-7 breast cancer cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 197-202.
|
[7] |
LUO Jiao, ZHANG Kunchi, ZHOU Li.
Analysis of differentially expressed microRNAs between the triple negative breast cancer cell line MDA-MB-231 and its brain metastasis cell line
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 218-224.
|
[8] |
ZHANG Yuling, WU Jundong, PANG Dongyue, CHEN Chunfa.
Changes of Ki67 expression before and after neoadjuvant chemotherapy as a predictor for therapeutic response and rognosis in breast cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 230-235,245.
|
[9] |
WANG Yaokun, CHEN Juexiao, ZHANG Mingyuan, SHAO Changli, YANG Yu, SHANG Yu.
Database analysis of genome variations and targeted drug screening of anaplastic thyroid cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 53-57.
|
[10] |
LI Weiwei, ZHU Ying.
Data mining analyses of expression and prognostic values of the MYB family in breast cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 414-422.
|
[11] |
CHEN Mianling, MA Shuoyi.
Regulation of migration and invasion of triple-negative breast cancer cell MDA-MB-231 by miR-21 via targeting PDCD4
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 292-297.
|
[12] |
ZHANG Huijuan, HUANG Dayuan, ZHANG Jie, TANG Haiou, XIE Anxin, TAN Dunyong.
Effects of SF1a-PRLR and ΔS2 SF1a-PRLR on proliferation and microRNA expressionin MCF-7 breast cancer cell
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 203-208.
|
[13] |
SUN Quanwu, DU Xiaoping, HAO Jie, SHI Rong, LIU Bo, HUANG Haiyun.
β1 integrin expression in breast cancer patients with pathological nipple discharge
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 368-372.
|
[14] |
WANG Lan, ZHANG Yongdong, GUO Hongyun, WANG Tao, WANG Haitao, GUO Huan, YANG Suisheng, LI Xiaoqin, SU Haixiang.
Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 392-396,400.
|
[15] |
DU Juan, HU Xiangyang, LIU Dan, HU Wei, CHEN Tao.
Inhibitory effect of total alkaloids of Tougucao on bone metastasis of breast cancer cells in mice
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 435-441.
|